Abstract
To investigate whether published results of industry funded trials of recombinant human bone morphogenetic protein 2 (rhBMP-2) in spinal fusion match underlying trial data by comparing three different data sources: individual participant data, internal industry reports, and publicly available journal publications and conference abstracts.
Original language | English |
---|---|
Pages (from-to) | f3981 |
Journal | BMJ |
Volume | 346 |
Publication status | Published - 2013 |